A. D. Beadell Investment Counsel Inc. Makes New $93,000 Investment in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

A. D. Beadell Investment Counsel Inc. purchased a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,000 shares of the pharmacy operator’s stock, valued at approximately $93,000.

Other institutional investors have also recently modified their holdings of the company. TD Private Client Wealth LLC grew its stake in Walgreens Boots Alliance by 8,670.3% in the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after acquiring an additional 3,208 shares during the period. Sentry Investment Management LLC purchased a new position in Walgreens Boots Alliance during the third quarter worth about $30,000. Eastern Bank acquired a new stake in Walgreens Boots Alliance in the 3rd quarter worth about $33,000. Strategic Investment Solutions Inc. IL purchased a new stake in Walgreens Boots Alliance in the 2nd quarter valued at about $34,000. Finally, Brooklyn Investment Group acquired a new position in shares of Walgreens Boots Alliance during the 3rd quarter valued at about $35,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Stock Up 21.8 %

WBA stock traded up $2.01 during trading on Friday, reaching $11.23. The stock had a trading volume of 56,352,022 shares, compared to its average volume of 24,640,979. The firm has a fifty day moving average price of $9.21 and a 200 day moving average price of $9.92. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $9.70 billion, a P/E ratio of -1.12, a PEG ratio of 1.36 and a beta of 0.64. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $24.93.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The firm had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. Walgreens Boots Alliance’s quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.66 EPS. On average, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, December 12th. Stockholders of record on Monday, November 18th were given a dividend of $0.25 per share. The ex-dividend date was Monday, November 18th. This represents a $1.00 annualized dividend and a dividend yield of 8.90%. Walgreens Boots Alliance’s payout ratio is -9.99%.

Analysts Set New Price Targets

WBA has been the topic of several research analyst reports. Truist Financial decreased their target price on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research report on Monday, October 7th. Morgan Stanley dropped their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th. Royal Bank of Canada reduced their target price on Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating on the stock in a report on Wednesday, December 4th. Evercore ISI upped their price target on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research note on Wednesday, October 16th. Finally, TD Cowen reduced their price objective on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, October 22nd. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $12.58.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.